HHS, AAP, Moderna, Stephen Hoge interview: Readout Newsletter

by AiNewsBlog Feb, 13

written by AiNewsBlog Feb, 13 0 comments

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The FDA’s surprise refusal to even review Moderna’s mRNA flu vaccine is sending a chill through biotech: Companies are openly wondering whether the regulatory goalposts are shifting under the Trump administration.

Programming note: This newsletter is taking a holiday on Monday but will be back in your inbox on Tuesday.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

AiNewsBlog

Hull City v Chelsea: FA Cup fourth round – live | FA Cup

Leave a Comment Cancel Reply

Name	Price	7d %	Volume
Bitcoin btc	$68,794	-2.65%	$45,087,931,369
Ethereum eth	$2,044	-0.94%	$21,003,743,236
XRP xrp	$1.41	-3.37%	$2,543,126,377
Solana sol	$85	-2.79%	$4,054,340,580
Dogecoin doge	$0.096	-2.86%	$875,923,400

At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.